TEPKINLY 4 mg/0,8 ml falc perf 4 mg 1 pce
7680691610011
CH-69161
L01FX27
1 / 3
google
Details
- GTIN
- 7680691610011
- Pharmacode
- -
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Tepkinly 4 mg/0.8 ml, Konzentrat zur Herstellung einer Injektionslösung
Konzentrat zur Herstellung einer Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
epcoritamabum
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
sorbitolum
|
21.84 MG | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.48 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 565.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2025
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 69161
- Drug name
- Tepkinly 4 mg/0,8 ml, Injektionslösung
- Galenic form
- KOINJ
- ATC Code
- L01FX27
- Authorization status
- B
- Dispensation category
- A
- First authorization
- 15/02/2024
- Authorization expiration date
- 05/05/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TEPKINLY 4 mg/0,8 ml falc perf 4 mg 1 pce
- Description (DE)
- TEPKINLY 4 mg/0,8 ml Durchstf 4 mg 1 Stk
- Market launch
- 15/02/2024
- Narcotic (BTM)
- No